Given the roles of these proteins in trophoblast migration in the developing placenta, together with their implication in metastasis of numerous tumor types, the SERPINE2-HTRA1-SDC4 axis constitutes a potential therapeutic target for the treatment of pre-eclampsia and various aggressive cancers. This evidence concerns the gene SDC4 and cancer.